New guidelines on how to treat hereditary breast cancer could be a gamechanger.
Internist Deanna Ternes, DO, grew up around hospitals and patients battling cancer.
Since the Ascension Via Christi CyberKnife Center opened its doors in 2006, the clinical team has used the system to provide highly precise, nonsurgical and noninvasive treatment to more than 4,000 patients with cancerous tumors and benign lesions.
New sustained-release implant treatment available for glaucoma patients
- 1 of 47
- next ›